Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2020

01-06-2020 | Thalassemia | Research article

The role of using different reference population in the prevalence of low BMD in the thalassemia patients

Authors: Mohammad Reza Mohajeri-Tehrani, Najmeh Darvishian, Faezeh Arab, Sedigheh Salemkar, Fariba Mohseni, Bagher Larijani, Zohreh Hamidi

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2020

Login to get access

Abstract

Purpose

Prevalence of osteoporosis reported as high as 50% in thalassemia major patients. We compared bone density (BMD) of our patients with results of bone densitometry of participants of a national study, to find if BMD diagnosis is ethnicity sensitive or not.

Methods

In 177 adult beta thalassemia major patients and 490 normal subjects of 20–39 y/o range, dual-energy X-ray absorptiometry of the spine and femur performed. Normal subjects participated in Iranian Multi-center Osteoporosis Study (IMOS). Mean and standard deviation of normal ones achieved and Z-score of patients re-calculated based on normal Iranians. As BMD of normal participants and patients performed by devices of different brands, analyses done based on calculated standard BMD of all participants.

Results

BMD of patients was significantly lower than normal participants (P value <0.001). Frequency of Z-score ≤−2 found in 52% and 56% of patients in femur and spine regions, respectively. New Z-score of patients according to Iranian normal populations calculated. Frequency of this new Z-score ≤−2 found in 16% and 72% of patients in femur and spine regions, respectively.

Conclusions

We think in secondary osteoporosis, may be other cut-off points, especially according to BMD of normal population of that geographical region are needed.
Literature
1.
go back to reference World Health Organization Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series no. 843. Geneva: WHO; 1994. World Health Organization Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series no. 843. Geneva: WHO; 1994.
3.
go back to reference Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for osteoporosis and bone disease. Osteoporos Int. 1997;7:390–406.CrossRefPubMed Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for osteoporosis and bone disease. Osteoporos Int. 1997;7:390–406.CrossRefPubMed
4.
go back to reference Bishop N, Braillon P, Burnham J, et al. Dual-energy X-ray aborptiometry assessment in children and adolescents withdiseases that may affect the skeleton: the 2007 ISCD pediatric official positions. J Clin Densitom. 2008;1:29–42.CrossRef Bishop N, Braillon P, Burnham J, et al. Dual-energy X-ray aborptiometry assessment in children and adolescents withdiseases that may affect the skeleton: the 2007 ISCD pediatric official positions. J Clin Densitom. 2008;1:29–42.CrossRef
6.
go back to reference Schonau E. Problems of bone analysis in childhood and adolescence. Pediatr Nephrol. 1998;12:420–42.CrossRefPubMed Schonau E. Problems of bone analysis in childhood and adolescence. Pediatr Nephrol. 1998;12:420–42.CrossRefPubMed
8.
go back to reference Muncie HL Jr, Campbell J. Alpha and Beta thalassemia. Am Fam Physician. 2009;80:339–44.PubMed Muncie HL Jr, Campbell J. Alpha and Beta thalassemia. Am Fam Physician. 2009;80:339–44.PubMed
9.
go back to reference Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with β thalassaemia. Br J Haematol. 2004;127:127–39.CrossRefPubMed Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with β thalassaemia. Br J Haematol. 2004;127:127–39.CrossRefPubMed
12.
go back to reference Lertsuwan K, Nammultriputtar K, Nanthawuttiphan S, Phoaubon S, Lertsuwan J, Thongbunchoo J, et al. Ferrous and ferric differentially deteriorate proliferation and differentiation of osteoblast-like UMR-106 cells. Biometals. 2018;31:873–89.CrossRefPubMed Lertsuwan K, Nammultriputtar K, Nanthawuttiphan S, Phoaubon S, Lertsuwan J, Thongbunchoo J, et al. Ferrous and ferric differentially deteriorate proliferation and differentiation of osteoblast-like UMR-106 cells. Biometals. 2018;31:873–89.CrossRefPubMed
13.
go back to reference Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A. Pathogenesis of Thalassemia Major-Associated Osteoporosis: Review of the Literature and Our Experience. J Clin Res Pediatr Endocrinol. 2019;28:110–17. Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A. Pathogenesis of Thalassemia Major-Associated Osteoporosis: Review of the Literature and Our Experience. J Clin Res Pediatr Endocrinol. 2019;28:110–17.
14.
15.
go back to reference Najafipour F, Aliasgarzadeh A, Aghamohamadzadeh N, Bahrami A, Mobasri M, Niafar M, et al. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major. Ann Saudi medicine. 2008;28:361.CrossRef Najafipour F, Aliasgarzadeh A, Aghamohamadzadeh N, Bahrami A, Mobasri M, Niafar M, et al. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major. Ann Saudi medicine. 2008;28:361.CrossRef
17.
go back to reference Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;162:139–46.CrossRefPubMed Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;162:139–46.CrossRefPubMed
18.
go back to reference Hamidi Z, Mohajeri-Tehrani M, Hamidieh AA, Naghghash A, Behfar M, Alimoghaddam K, et al. How thalassemia affects endocrinological, BMD and bone metabolism parameters - a cross sectional study. Ann Clin Lab Res. 2019;7:293. Hamidi Z, Mohajeri-Tehrani M, Hamidieh AA, Naghghash A, Behfar M, Alimoghaddam K, et al. How thalassemia affects endocrinological, BMD and bone metabolism parameters - a cross sectional study. Ann Clin Lab Res. 2019;7:293.
19.
go back to reference Hamidieh AA, Hamidi Z, Nedaeifard L, et al. Bone mineral density in ex-thalassemic pediatric patients. Hematol Oncol Stem Cell Ther. 2012;5:70–1.CrossRefPubMed Hamidieh AA, Hamidi Z, Nedaeifard L, et al. Bone mineral density in ex-thalassemic pediatric patients. Hematol Oncol Stem Cell Ther. 2012;5:70–1.CrossRefPubMed
20.
go back to reference Argentiero A, Neglia C, Peluso A, et al. The ability of lumbar spine DXA and phalanx QUS to detect previous fractures in young Thalassemic patients with Hypogonadism, hypothyroidism, diabetes, and hepatitis-B: a 2-year subgroup analysis from the Taranto area of Apulia region. J Pediatr Hematol Oncol. 2013;35:e260–4.CrossRefPubMedPubMedCentral Argentiero A, Neglia C, Peluso A, et al. The ability of lumbar spine DXA and phalanx QUS to detect previous fractures in young Thalassemic patients with Hypogonadism, hypothyroidism, diabetes, and hepatitis-B: a 2-year subgroup analysis from the Taranto area of Apulia region. J Pediatr Hematol Oncol. 2013;35:e260–4.CrossRefPubMedPubMedCentral
21.
go back to reference Hamidi Z, Sedaghat M, Mortaz Hejri S, Larijani B. Defining cut-off values for the diagnosis of osteoporosis in postmenopausal women by quantitative ultrasonography of the phalanx. Gynecol Endocrinol. 2008;24:546–8.CrossRefPubMed Hamidi Z, Sedaghat M, Mortaz Hejri S, Larijani B. Defining cut-off values for the diagnosis of osteoporosis in postmenopausal women by quantitative ultrasonography of the phalanx. Gynecol Endocrinol. 2008;24:546–8.CrossRefPubMed
22.
go back to reference Hamidieh AA, Hamidi Z, Nedaeifard L, et al. Changes of bone density in pediatric patients with-thalassemia major after Allogenic hematopoietic stem cell transplantation. Arch Iran Med. 2013;16:88–92.PubMed Hamidieh AA, Hamidi Z, Nedaeifard L, et al. Changes of bone density in pediatric patients with-thalassemia major after Allogenic hematopoietic stem cell transplantation. Arch Iran Med. 2013;16:88–92.PubMed
23.
go back to reference Gaudio A, Morabito N, Xourafa A, et al. Role of genetic pattern on bone mineral density in thalassemic patients. Clin Biochem. 2010;43:805–7.CrossRefPubMed Gaudio A, Morabito N, Xourafa A, et al. Role of genetic pattern on bone mineral density in thalassemic patients. Clin Biochem. 2010;43:805–7.CrossRefPubMed
26.
go back to reference Genant, H K. Grampp, S. Gluer, C C. Faulkner, K G. Jergas, M. Engelke, K. et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. Journal of bone and mineral research, 1994. 9, 1503-14. Genant, H K. Grampp, S. Gluer, C C. Faulkner, K G. Jergas, M. Engelke, K. et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. Journal of bone and mineral research, 1994. 9, 1503-14.
27.
go back to reference Mohseni F, Mohajeri-Tehrani MR, Larijani B, Hamidi Z.: Correlation between criteria of diagnosis of low bone mineral density in adult and pediatric thalassemic patients: a prospective study. Minerva Pediatr. 2015; Nov 19. PMID: 26583453. Mohseni F, Mohajeri-Tehrani MR, Larijani B, Hamidi Z.: Correlation between criteria of diagnosis of low bone mineral density in adult and pediatric thalassemic patients: a prospective study. Minerva Pediatr. 2015; Nov 19. PMID: 26583453.
28.
go back to reference Hamidi Z, Mohseni F , Mohajeri -Tehrani MR, Pajouhi M, Larijani B. Examining Z-score lower than -2 as a cut-off point for low BMD in children with chronic disease: Thalassemia an example. Osteoporos Int. 2015; 26 (Suppl 2):S445. Hamidi Z, Mohseni F , Mohajeri -Tehrani MR, Pajouhi M, Larijani B. Examining Z-score lower than -2 as a cut-off point for low BMD in children with chronic disease: Thalassemia an example. Osteoporos Int. 2015; 26 (Suppl 2):S445.
29.
go back to reference MOHSENI F, MOHAJERI-TEHRANI MR, LARIJANI B, HAMIDI Z. Bone density changes in thalassemic patients with age and time. HK J Paediatr (new series) 2016; 21 :257-261 . MOHSENI F, MOHAJERI-TEHRANI MR, LARIJANI B, HAMIDI Z. Bone density changes in thalassemic patients with age and time. HK J Paediatr (new series) 2016; 21 :257-261 .
30.
go back to reference Moayyeri A, Soltani A, Tabari NK, Sadatsafavi M, Hossein-Neghad A, Larijani B. Discordance in diagnosis of osteoporosis using spine and hip bone densitometry. BMC Endocr Disord. 2005 ; 11;5(1):3. Moayyeri A, Soltani A, Tabari NK, Sadatsafavi M, Hossein-Neghad A, Larijani B. Discordance in diagnosis of osteoporosis using spine and hip bone densitometry. BMC Endocr Disord. 2005 ; 11;5(1):3.
31.
go back to reference Park KH, Lim JS, Kim KM, Rhee Y, Lim SK. Z-score discordance and contributing factors in healthy premenopausal women with low bone mineral density: the Korean National Health and Nutrition Examination Survey 2008-9. J Bone Miner Metab. 2015 Oct 7. Park KH, Lim JS, Kim KM, Rhee Y, Lim SK. Z-score discordance and contributing factors in healthy premenopausal women with low bone mineral density: the Korean National Health and Nutrition Examination Survey 2008-9. J Bone Miner Metab. 2015 Oct 7.
35.
go back to reference Larijani B, Moayyeri A, Keshtkar AA, et al. Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study. J Clin Densitom. 2006 Jul-Sep;9(3):367-74. Larijani B, Moayyeri A, Keshtkar AA, et al. Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study. J Clin Densitom. 2006 Jul-Sep;9(3):367-74.
Metadata
Title
The role of using different reference population in the prevalence of low BMD in the thalassemia patients
Authors
Mohammad Reza Mohajeri-Tehrani
Najmeh Darvishian
Faezeh Arab
Sedigheh Salemkar
Fariba Mohseni
Bagher Larijani
Zohreh Hamidi
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-019-00455-6

Other articles of this Issue 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine